Met Life Investment Management, LLC Fulgent Genetics, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 12,855 shares of FLGT stock, worth $213,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,855
Previous 12,855 -0.0%
Holding current value
$213,778
Previous $279,000 15.05%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$19.09 - $22.57 $20,979 - $24,804
1,099 Added 9.35%
12,855 $252,000
Q1 2024

May 14, 2024
BUY
$21.55 - $29.29 $253,341 - $344,333
11,756 New
11,756 $255,000
Q2 2023

Apr 29, 2024
BUY
$28.52 - $40.7 $335,281 - $478,469
11,756 New
11,756 $435,000
Q1 2023

May 09, 2024
BUY
$29.39 - $36.27 $345,508 - $426,390
11,756 New
11,756 $367 Million
Q1 2022

May 10, 2024
BUY
$49.85 - $96.11 $586,036 - $1.13 Million
11,756 New
11,756 $733,000
Q1 2022

Mar 22, 2023
BUY
$49.85 - $96.11 $216,299 - $417,021
4,339 Added 58.5%
11,756 $733,000
Q1 2022

May 12, 2022
BUY
$49.85 - $96.11 $216,299 - $417,021
4,339 Added 58.5%
11,756 $734,000
Q4 2021

Jun 21, 2023
SELL
$77.3 - $105.0 $335,404 - $455,595
-4,339 Reduced 36.91%
7,417 $746,000
Q3 2021

Jun 21, 2023
SELL
$74.87 - $110.87 $324,860 - $481,064
-4,339 Reduced 36.91%
7,417 $667,000
Q2 2021

May 17, 2024
BUY
$66.8 - $100.45 $157,915 - $237,463
2,364 Added 46.78%
7,417 $684,000
Q2 2021

Jun 21, 2023
SELL
$66.8 - $100.45 $289,845 - $435,852
-4,339 Reduced 36.91%
7,417 $684,000
Q2 2021

Mar 22, 2023
BUY
$66.8 - $100.45 $157,915 - $237,463
2,364 Added 46.78%
7,417 $684,000
Q2 2021

Aug 16, 2021
BUY
$66.8 - $100.45 $157,915 - $237,463
2,364 Added 46.78%
7,417 $684,000
Q1 2021

May 17, 2024
SELL
$59.3 - $183.85 $397,487 - $1.23 Million
-6,703 Reduced 57.02%
5,053 $488,000
Q1 2021

Jun 26, 2023
SELL
$59.3 - $183.85 $397,487 - $1.23 Million
-6,703 Reduced 57.02%
5,053 $488 Million
Q4 2020

Jun 22, 2023
SELL
$31.01 - $52.1 $207,860 - $349,226
-6,703 Reduced 57.02%
5,053 $263,000
Q3 2020

May 24, 2024
SELL
$15.89 - $50.51 $106,510 - $338,568
-6,703 Reduced 57.02%
5,053 $202 Million
Q3 2020

Jun 26, 2023
SELL
$15.89 - $50.51 $106,510 - $338,568
-6,703 Reduced 57.02%
5,053 $202,000
Q3 2020

Mar 22, 2023
SELL
$15.89 - $50.51 $106,510 - $338,568
-6,703 Reduced 57.02%
5,053 $202,000
Q3 2020

Nov 13, 2020
BUY
$15.89 - $50.51 $80,292 - $255,227
5,053 New
5,053 $202,000

Others Institutions Holding FLGT

# of Institutions
207
Shares Held
17.1M
Call Options Held
2.36M
Put Options Held
47.9K
View Full List

About Fulgent Genetics, Inc.

FLGT Quotes by TradingView
  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $503M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email